FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Proven efficacy across all three key markers of disease—68% reduction in proteinuria,…
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
July 25, 2025 16:15 ET | Source: Portage Biotech Inc. DOVER, Del.,…
Diginex Announces Execution of Warrants Agreement, Bonus Share Issuance and Cancelation of EGM
July 25, 2025 20:00 ET | Source: Diginex Limited LONDON, July 25,…
SIMPPLE Ltd. Fully Regains Compliance with Nasdaqs Continued Listing Requirements
Singapore, July 24, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE”…
UPDATEBrag House Announces $15 Million Private Placement
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc.…
Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts
BEAVERTON, Ore., July 22, 2025 (GLOBE NEWSWIRE) -- Datavault AI Inc. (NASDAQ:…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
July 18, 2025 16:05 ET | Source: HOOKIPA Pharma Inc. NEW YORK…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 18, 2025 17:15 ET | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…
CloudFirst to Join Performive in Strategic Growth Transaction
Data Storage Subsidiary Sale Subject to Shareholder Approval July 15, 2025 16:45…